Haw Par Corporation Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Haw Par Corporation Limited with three other
pharmaceutical manufacturers in Asia:
Jacobson Pharma Corporation Ltd
of Hong Kong
sales of 1.26 billion Hong Kong Dollars [US$160.39 million]
of which 87%
was Generic drugs),
Ahn-Gook Pharmaceutical Co., Limited.
of South Korea
(183.60 billion Korean Won [US$162.12 million]
Beijing Tong Ren Tang Chinese Medicine Company Limited
based in Hong Kong
(1.27 billion Hong Kong Dollars [US$161.67 million]
of which 50%
was Healthcare products and Chinese medicine).
Haw Par Corporation Limited reported sales of 222.76 million Singapore Dollars (US$161.54 million)
December of 2017.
increase of 10.5%
versus 2016, when the company's sales were 201.64 million Singapore Dollars.
Sales at Haw Par Corporation Limited have increased during each of the previous five years
(and since 2012, sales have increased a total of 60%).